LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Overview Fund Activity
Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

88 hedge funds and large institutions have $19.5M invested in Lumos Pharma, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 25 reducing their positions, and 19 closing their positions.

Holders
88
Holders Change
-5
Holders Change %
-5.38%
% of All Funds
1.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
18
Reduced
25
Closed
19
Calls
$35K
Puts
$34K
Net Calls
+$1K
Net Calls Change
+$38K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$3.13M
2
AFM
2
Anson Funds Management
Texas
$429K
3
OAM
3
Oxford Asset Management
United Kingdom
$907K
4
PAM
4
Panagora Asset Management
Massachusetts
$1.07M
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$571K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.3M
2
Axa
2
Axa
France
$0
3
CS
3
Candriam SCA
Luxembourg
$0
4
BlackRock
4
BlackRock
New York
$2.85M
5
TCM
5
Tekla Capital Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
APP
101
Avantax Planning Partners
Iowa
– – -105 Closed
SO
102
STRS Ohio
Ohio
$0 500 – –
Wolverine Trading
103
Wolverine Trading
Illinois
– – – –
GRP
104
Global Retirement Partners
California
$0 100 – –
WAM
105
Wolverine Asset Management
Illinois
$0 2 – –
QT
106
Quantamental Technologies
New York
$0 22 +22 New
FGC
107
Financial Gravity Companies
Texas
$0 24 +24 New
LC
108
Lindbrook Capital
California
$0 551 +551 New
1 2 3 4
5